Publication | Open Access
MitraClip® Therapy in Patients with End-Stage Systolic Heart Failure
314
Citations
17
References
2011
Year
MitraClip® therapy reduces functional MR in patients with end-stage heart failure and marked LV dysfunction and entails clinical benefit at 6 months.
| Year | Citations | |
|---|---|---|
Page 1
Page 1